Kindolor pain drug study halted after early safety check
NCT ID NCT06243835
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 28 times
Summary
This early-stage study aimed to find a safe dose of Kindolor Tosylate, a potential pain treatment, in 16 healthy adults. Participants received either the drug or a placebo and were monitored for side effects and how the body processes the drug. The study was terminated early, so no conclusions about effectiveness were drawn.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Altman Clinical and Translational Research Institute
La Jolla, California, 92037, United States
Conditions
Explore the condition pages connected to this study.